Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001807094-20-000006
Filing Date
2020-05-05
Accepted
2020-05-05 21:27:20
Documents
2
Period of Report
2020-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 38538
2 LPOA lpoasp.txt EX-24 4178
  Complete submission text file 0001807094-20-000006.txt   44243
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTODYN INC. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Kelly Scott A. (Reporting) CIK: 0001703394 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 20850910